SOPH SOPHIA GENETICS SA

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the . Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit  and connect with us on .



Investor Contact
Kellen Sanger
 

Media Contact 
Kelly Katapodis
EN
23/04/2024

Underlying

SOPHSOPHIA GENETICS SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SOPHIA GENETICS SA

 PRESS RELEASE
Free
SOPH SOPHIA GENETICS...

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Heal...

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT. The presentation will be webcast live on the . Additionally, a replay will be available on the website after its completion. About ...

April 30, 2024 1 EN
 PRESS RELEASE
Free
SOPH SOPHIA GENETICS...

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 o...

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024 BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on ...

April 23, 2024 1 EN
 PRESS RELEASE
Free
SOPH SOPHIA GENETICS...

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthca...

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024, at 2:35 p.m. EDT. The fireside chat will be webcast live on the . Additionally, a replay will be available on the website after its comple...

March 7, 2024 1 EN
 PRESS RELEASE
Free
SOPH SOPHIA GENETICS...

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results Strong momentum to continue in 2024 as SOPHiA GENETICS announces record revenue, 35 new customer additions in Q4, and 36% cash burn decline in FY 2023 BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Revenue grew 27% year-over-year to $17.0 million; Constant currency ...

March 5, 2024 1 EN
 PRESS RELEASE
Free
SOPH SOPHIA GENETICS...

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD ...

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference BOSTON and ROLLE, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Chief Executive Officer, Dr. Jurgi Camblong, and Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Wednesday, March 6, 2024, at 10:30 a.m. EDT. The fireside chat will be webcast live on the . ...

February 22, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch